Effective measures for the secondary prevention of<unk>  include biochemical screening for family members of MEN2 patients is mandatory and Genetic testing in first-degree relatives of a patient with proven germline RET mutation.
Pheochromocytoma secondary prevention
Hypoaldosteronism secondary prevention
Pheochromocytoma medical therapy
Primary hyperaldosteronism medical therapy
Hypoaldosteronism medical therapy
Malignant hypertension medical therapy
Adrenocortical carcinoma secondary prevention
Renal artery stenosis medical therapy